Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2000-Year of the Biotechs! -- Ignore unavailable to you. Want to Upgrade?

To: Volcano888 who wrote (430)	3/2/2000 3:42:00 PM
From: Don England	Read Replies (1) \| Respond to of 1142

vol, the science-heads don't always reply, so i'll make a minor stab. they had positive results on their lupus drug from, as i recall, phase 3 trials, and the presentation on the results went favorably according to the co. things go to hell after that. an analyst, name of augustine, panned the results, reported the meeting in a grossly disimilar manner to that of the co., and the stock tanked from a hot run over 13 to about 9. has been basing 9 to 11 for days and days. i have been a buyer here and am sitting on a couple of thousand with great hopes. another firm has placed a $20 value on their shares. if the lupus results hold they are worth it. something must be afoot as they have moved very well today. hope this helps. don